SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " cannabinoid " 10 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
cbdMD, Inc. (NYSE American: YCBD), a leading innovator in hemp-derived wellness products, today announced a strategic initiative to integrate and expand its regulatory science, safety, and intellectual property assets to establish a differentiated cannabinoid compliance and evidence platform aligned with evolving federal healthcare evaluation frameworks, including emerging CMS and CMMI innovation initiatives.
New York approves cannabis for anxiety. Science says it may not help
A Lancet Psychiatry study found no evidence cannabinoids treat anxiety, PTSD. In NY, any practitioner can certify a patient for medical cannabis for any condition they deem appropriate.
Scientists “resurrect” ancient cannabis enzymes with medical promise
Scientists have uncovered how cannabis evolved the ability to make its most famous compounds—THC, CBD, and CBC—by recreating ancient enzymes that existed millions of years ago. These early enzymes were multitaskers, capable of producing several cannabinoids at once, before evolution fine-tuned them into today’s highly specialized forms. By “resurrecting” these long-lost enzymes in the lab, researchers showed how cannabis chemistry became more precise over time—and discovered something unexpected: the ancient versions are often more robust and easier to work with.
Cannabis and Health: How Cannabinoids Affect the Human Body
Dietary cannabinoids such as CBD show anti-inflammatory and immunomodulatory activity in experimental studies, but evidence that supplementation improves human health remains limited.
CBIH Announces Expanded Research Strategy at the Intersection of Endocannabinoid Science and Biological Medicine
Houston, Texas--(Newsfile Corp. - October 19, 2026) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced an expansion of its scientific research strategy focused on the intersection of endocannabinoid biology, precision medicine, and the development of intellectual property with potential biomedical applications."We are witnessing a new era in the history of medicine: an era in which human biology
Marion creates licensing structure for tobacco, vapes, hemp products
MARION — The Marion city council approved a new licensing structure for vendors selling tobacco, nicotine, electronic smoking and hemp-derived cannabinoid products.
Denton businesses prepare for more THC products to be banned July 31
Starting Friday, Texas will prohibit the sale of smokeable products containing delta-8, delta-10 and several other intoxicating cannabinoids. Delta-9 products are not included in the ban.
Gov. Greg Abbott cleared the way for the hemp industry in 2019. Now businesses are being pushed out
Texas will ban hemp products containing certain intoxicating cannabinoids starting July 31, and local businesses are feeling the strain — and even closing.
Why a cannabis business is betting on dogs to reach FDA approval
Endovia is pursuing FDA veterinary approval for its cannabinoid drug targeting canine cancer and chronic pain in the companion-animal market.
Life Sciences Companies Present Live at the September 17 Virtual Investor Forum
Live Presentations and Q&A Across Oncology, Fibrosis, Drug Delivery, Antibiotics, Cannabinoid Therapeutics, and Respiratory Imaging A Global Lineup Presents Live Online: 30-Minute Sessions, Audience Q&A, Replays On Demand NEW YORK, NY - Sept...